Biogen shares slump after Samsung Biologics denial of buyout report

28608 biogen shares slump after samsung biologics denial of buyout report

Steven Goldstein is based in London and responsible for MarketWatch’s coverage of financial markets in Europe, with a particular focus on global macro and commodities. Previously, he was Washington bureau chief, directing MarketWatch’s economic, political and regulatory coverage. Follow Steve on Twitter: @MKTWgoldstein.

Source: Marketwatch

Related Posts